As of February 25, 2025, PMGC’s capital structure is as follows: Common Shares Outstanding: 4,042,295. Stock Options Outstanding: 4,931 shares of Common Stock issuable upon the exercise of ...

PMGC Holdings Inc. NEWPORT BEACH, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-7 ...

NEWPORT BEACH, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-7 reverse stock split (the ...

PMGC (ELAB) announced its annual sponsorship of TCA Venture Group’s Orange County network for 2025. TCA Venture Group, formerly known as Tech Coast Angels, is an angel investor network with a ...

In a recent development, PMGC Holdings Inc. (NASDAQ:PMGC), a pharmaceutical company specializing in preparations for medical aesthetics with a market capitalization of $3.83 million, has mutually ...

NEWPORT BEACH, Calif. - PMGC Holdings Inc. (NASDAQ: ELAB), a Nevada-based corporation, has declared a 1-for-7 reverse stock split of its common stock, set to take effect at midnight Eastern time on ...

NEWPORT BEACH, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the "Company," "PMGC," "us," or "we") (Nasdaq:ELAB), a diversified holding company, today ...

PMGC Holdings remains dedicated to innovative solutions and delivering long-term value for its shareholders. About PMGC Holdings Inc. PMGC Holdings Inc. is a diversified holding company that ...

NEWPORT BEACH, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) ("PMGC” or the "Company”) today announced that it will effect a 1-for-7 reverse stock split (the "Split”) of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(RTTNews) - Northstrive Biosciences, a subsidiary of PMGC Holdings Inc. (ELAB), on Tuesday announced the submission of a pre-investigational New Drug or pre-IND meeting request to the FDA for EL-22.

Purpose of the Reverse Stock Split: The reverse stock split is a critical step in ensuring compliance with Nasdaq’s listing requirements, allowing PMGC to maintain its presence on The Nasdaq Capital ...